SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 205.63+1.0%11:29 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (9808)10/21/1997 1:12:00 AM
From: Andrew H  Read Replies (1) of 32384
 
>>What most posters fail to understand is the importance of this agreement to LLY. They are using LGND's technnology to move their research into the next mellinium. LGND will harness an extraordinary share of LLY's R&D budget for developing potent oral treaments for several metabolic diseases, including but certainly not limited to diabetes.

It was NOT a coincidence that LGND and LLY were on CNBC today, nor was it a coincidence that the deal was announced on the same day as LLY's earnings.<<

If such is the case, we should get a couple of new brokerage coverages and recommendations before too long.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext